Allergic and latex-specific sensitization: Route, frequency, and amount of exposure that are required to initiate IgE production - 10/05/12
Abstract |
Quantitative data that documents human exposure-response relationships for IgE sensitization to allergens are limited. Although seemingly straightforward, documentation of exposure-response relationships can be difficult. Issues that are related to study design, allergen standardization, exposure assessment, and evaluation for sensitization can impact greatly on study results. Despite these issues, exposure-response relationships for sensitization to protein allergens have been documented in several occupational groups, which include enzyme-detergent workers, bakers, and laboratory animal workers. In general, atopy acts as an effect modifier in these settings, steepening the exposure-response relationship. Several studies suggest that the greatest risk for sensitization is within the first several years of exposure. For 1 allergen, the protease subtilisin, a short-term exposure limit of 60 ng/m3 has been recommended by the American Council of Governmental Industrial Hygienists. With regard to natural rubber latex, exposure-related factors such as number of operations have been shown to be risk factors for sensitization of children with spina bifida. By contrast, fewer studies show exposure-response relationships for IgE sensitization of health care workers to natural rubber latex, and the area remains controversial. However, a recent cohort study that evaluated incident sensitization in dental hygiene students suggests strongly that, with sufficient exposure, employment in health care can lead to an increased risk of IgE sensitization to natural rubber latex. (J Allergy Clin Immunol 2002;110:S57-63.)
Le texte complet de cet article est disponible en PDF.Keywords : Latex, IgE, sensitization, exposure-response
Abbreviations : HCW, NRL
Plan
| Drs Weissman and Lewis have no significant financial interest in the commercial sponsors of this publication. They attest that there are no commercial or personal conflicts of interest. |
|
| Reprint requests: David N. Weissman, MD, NIOSH/HELD/ASB, Mailstop L-4218, 1095 Willowdale Road, Morgantown, WV 26505; e-mail: dweissman@cdc.gov . |
Vol 110 - N° 2S
P. S57-S63 - août 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
